Andrew Zhu
MD PhD
Professor
👥Biography 个人简介
Andrew Zhu contributed to landmark HCC clinical research including the SHARP trial establishing sorafenib as first systemic therapy to improve survival in advanced HCC — a watershed moment in liver cancer treatment. His extensive contributions to HCC clinical trials spanning sorafenib, lenvatinib, immune checkpoint inhibitors, and combination strategies have helped define modern HCC treatment algorithms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Andrew Zhu 的研究动态
Follow Andrew Zhu's research updates
留下邮箱，当我们发布与 Andrew Zhu（Jiahui International Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment